Professional
Added to YB: 2024-11-12
Pitch date: 2024-09-30
GALD.SW [bullish]
Galderma Group AG
+111.45%
current return
Author Info
No bio for this author
Company Info
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.
Market Cap
CHF 22.7B
Pitch Price
CHF 78.84
Price Target
N/A
Dividend
N/A
EV/EBITDA
29.03
P/E
-38.2K
EV/Sales
5.84
Sector
Pharmaceuticals
Category
growth
Artisan Global Discovery Fund Added On Position: Galderma Group
GALD.SW added to position: Leading dermatology co. with strong aesthetics portfolio & $1B+ Cetaphil brand. Expects to outgrow market, expand margins. Nemluvio approval for atopic dermatitis/prurigo nodularis - potential $2B opportunity. Margins to improve as clinical trials end.
Read full article (1 min)